Search Results for "Brian Groves Pfizer Bio"

01:31 EST 28th January 2015 | BioPortfolio

Original Source: Advil® Launches Advil® Relief in Action Campaign Celebrating Active Volunteers Who Don’t Let Pain Hold Them Back

Pfizer Consumer Healthcare (NYSE: PFE), makers of Advil®, is kicking off its Advil® Relief in Action campaign today that honors volunteers who don’t let pain get in the way of providing relief to others in need. Advil® Relief in Action celebrates the efforts of these tireless everyday heroes, as well as supports and contributes to the efforts of Habitat for Humanity and Wounded Warrior Project® (WWP), whose volunteers exemplify Relief in Action and work...

Matching Channels


Pfizer is a global pharmaceutical company, the largest in world based on annual sales.  In 2009, annual sales were worth $45,448m. Pfizer spend £550m on R&D in the UK alone, and have ...

CTLA4 Mab rDNA Pfizer

Insulin rDNA inhaled Pfizer

Lymphocyte Immune Globulin Pfizer

Somatropin Hgh rDNA Pfizer

What is GENOTROPIN? GENOTROPIN (somatropin [rDNA origin] for injection) is a growth hormone treatment. It is an exact copy of the natural growth hormone that our bodies make. The main difference i...

Matching News

Pfizer leaves investors guessing on intentions for Astra

Pfizer Inc , which in May abandoned its $118 billion bid to buy AstraZeneca Plc , on Tuesday left investors guessing whether it would renew its pursuit of its British rival, but said it was considerin...

Is Pfizer’s next acquisition target, Activas?

Bloomberg reports, Pfizer is looking at Actavis, the generics maker with a new home address in Ireland, among other targets. Pfizer may not get a great shot at buying AstraZeneca this fall–but...

AstraZeneca shores up defences against Pfizer

AstraZeneca has been making a series of big deals over the past three months as it looks to close the door once and for all on any Pfizer merger.  AZ rebuffed Pfizer’s $118 billion offer for th...

BRIEF-Pfizer reaches $35 mln settlement over marketing of Rapamune

Aug 6 (Reuters) - Pfizer Inc : * Ny ag schneiderman says Pfizer Inc has reached $35 million settlement

Will Pfizer Circle Back to Get AZN?

Pfizer isn't in great shape given its current pipeline potential and residence in a high tax jurisdiction. Pfizer's CEO Read says that US companies are at a tremendous competitive disadvantage with th...

Pfizer could try to acquire Actavis as back-up to a further bid for AstraZeneca

While speculation continues as to whether Pfizer will resume its attempts to buy AstraZeneca, Pfizer is reportedly looking to buy Ireland-headquartered generics major Actavis, according to sources clo...

Pfizer: You Won't Fool Me Twice

By Marshall Hargrave:Pfizer (NYSE:PFE) tried to buy up AstraZeneca (NYSE:AZN) back in May in an effort to take advantage of the tax inversion craze. But AstraZeneca rejected the bid, noting that the $...

Brian Malmgren Memorial Fund Established

(PRWEB) August 04, 2014 On the afternoon of July 30th, 2014, Brian Malmgren passed away due to complications associated with Myotonic Dystrophy. At age 43, Brian had lived a full, and at times, ver...

Matching PubMed Articles

Search Whole site using Google

Search BioPortfolio:
Advertisement Advertisement